서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 44 of 44

Issue DateTitle / Author(s) / CitationFileAltmetrics
2009-02
Ramosetron for the Prevention of Nausea and Vomiting During 5-Fluorouracil-Based Chemoradiotherapy for Pancreatico-biliary Cancer

Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W.

Japanese Journal of Clinical Oncology, Vol.39 No.2, pp.111-115

DOI
2009-05
Does Adjuvant Radiotherapy Suppress Liver Regeneration After Partial Hepatectomy?

Choi, Jin-Hwa; Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W.

International Journal of Radiation Oncology Biology Physics, Vol.74 No.1, pp.67-72

DOI
2009-09
Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: Which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study
DOI
2009-10
Role of Adjuvant Chemoradiotherapy for Ampulla of Vater Cancer

Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W.

International Journal of Radiation Oncology Biology Physics, Vol.75 No.2, pp.436-441

DOI
2010-07
Is Duodenal Invasion a Relevant Prognosticator in Patients Undergoing Adjuvant Chemoradiotherapy for Distal Common Bile Duct Cancer?

Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W.

International Journal of Radiation Oncology Biology Physics, Vol.77 No.4, pp.1186-1190

DOI
2011-05
Diagnostic performance of contrast enhanced CT and 18F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection
DOI
2012-04
Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: A long-term single center experience
DOI
2012-05
Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma
DOI
2012-09
Distant metastasis risk stratification for patients undergoing curative resection followed by adjuvant chemoradiation for extrahepatic bile duct cancer

Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W.

International Journal of Radiation Oncology Biology Physics, Vol.84 No.1, pp.81-87

DOI
2012-12
Role of Adjuvant Chemoradiotherapy for Duodenal Cancer A Single Center Experience

Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W.

American Journal of Clinical Oncology, Vol.35 No.6, pp.533-536

DOI
2013-03
CD24 expression predicts distant metastasis in extrahepatic bile duct cancer
DOI
2013-11
Nomogram Prediction of Survival and Recurrence in Patients With Extrahepatic Bile Duct Cancer Undergoing Curative Resection Followed by Adjuvant Chemoradiation Therapy

Song, Changhoon; Kim, Kyubo; Chie, Eui Kyu; Kim, Jin Ho; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W.

International Journal of Radiation Oncology Biology Physics, Vol.87 No.3, pp.499-504

DOI
2014-11
Chemoradiotherapy for Extrahepatic Bile Duct Cancer with Gross Residual Disease after Surgery
2015-10
High ratio of programmed cell death protein 1 (PD-1)(+)/CD8(+) tumor-infiltrating lymphocytes identifies a poor prognostic subset of extrahepatic bile duct cancer undergoing surgery plus adjuvant chemoradiotherapy
DOI
2016-03
Survival outcomes according to adjuvant treatment and prognostic factors including host immune markers in patients with curatively resected ampulla of vater cancer
DOI
2016-08
Prognostic Significance of Nodal Ratio in Patients Undergoing Adjuvant Chemoradiotherapy After Curative Resection for Ampullary Cancer
DOI
2016-10
Outcome Analysis of Chemoradiation in Unresectable Pancreatic Cancer Focusing on Treatment Sequencing Strategy
DOI
2017-04
Clinical Implications of Cytotoxic T Lymphocyte Antigen-4 Expression on Tumor Cells and Tumor-Infiltrating Lymphocytes in Extrahepatic Bile Duct Cancer Patients Undergoing Surgery Plus Adjuvant Chemoradiotherapy
DOI
2017-04
Long-Term Outcome of Distal Cholangiocarcinoma after Pancreaticoduodenectomy Followed by Adjuvant Chemoradiotherapy: A 15-Year Experience in a Single Institution
DOI
2017-05
Risk stratification and prognostic nomogram for postrecurrence overall survival in patients with recurrent extrahepatic cholangiocarcinoma
DOI
2017-09
Impact of radiation dose in postoperative radiotherapy after R1 resection for extrahepatic bile duct cancer: long term results from a single institution
DOI
2017-11
Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel
DOI
2018-03
The impact of perioperative CA19-9 change on the survival and recurrence patterns after adjuvant chemoradiotherapy in resectable extrahepatic cholangiocarcinoma

Kim, Byoung Hyuck; Kim, Eunji; Kim, Kyubo; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Chie, Eui Kyu

Journal of Surgical Oncology, Vol.117 No.3, pp.380-388

DOI
2018-05
High expression of MMP-9 is associated with better prognosis in extrahepatic bile duct cancer patients

Park, Younghee; Kim, Kyubo; Paik, Jin Ho; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn

European Journal of Surgical Oncology, Vol.44 No.5, pp.638-643

DOI
2019-08
Clinically Applicable Deep Learning Algorithm Using Quantitative Proteomic Data

Kim, Hyunsoo; Kim, Yoseop; Han, Buhm; Jang, Jin-Young; Kim, Youngsoo

Journal of Proteome Research, Vol.18 No.8, pp.3195-3202

DOI
2020-08
Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate
DOI
2020-11
Survival benefit of adjuvant chemoradiotherapy for positive or close resection margin after curative resection of pancreatic adenocarcinoma
DOI
2021-06
A Clinically Applicable 24-Protein Model for Classifying Risk Subgroups in Pancreatic Ductal Adenocarcinomas using Multiple Reaction Monitoring-Mass Spectrometry
DOI
2021-10
The Role of Adjuvant Chemoradiotherapy in Nonhilar Extrahepatic Bile Duct Cancer: A Long-Term Single-Institution Analysis

Chang, Won Ick; Kim, Byoung Hyuck; Kang, Hyun-Cheol; Kim, Kyubo; Lee, Kyung-Hun; Oh, Do-Youn; Kim, Hongbeom; Kwon, Wooil; Jang, Jin-Young; Chie, Eui Kyu

International Journal of Radiation Oncology Biology Physics, Vol.111 No.2, pp.395-404

DOI
2021-10
Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancreatic Cancer
DOI
2021-11
Role of adjuvant radiotherapy in extrahepatic bile duct cancer: A multicenter retrospective study (Korean Radiation Oncology Group 18-14)
DOI
2022-01
The incidence and clinical features of familial pancreatic cancer in Korea
DOI
2022-01
Radiological tumour invasion of splenic artery or vein in patients with pancreatic body or tail adenocarcinoma and effect on recurrence and survival
DOI
2022-01
p Oncologic outcomes according to the location and status of resection margin in pancreas head cancer: role of radiation therapy in R1 resection
DOI
2022-03
Standardization of Pathologic Sampling and Evaluation of Gallbladder Specimens: Recommendations of the International Study Group on Gallbladder Cancer (ISG-GBC) of International Hepato-Pancreato-Biliary Association (IHPBA)
2022-05
Can Surgical Resection of Metastatic Lesions Be Beneficial to Pancreatic Ductal Adenocarcinoma Patients with Isolated Lung Metastasis?
DOI
2022-05
Predicting prognosis and evaluating the benefits of adjuvant chemotherapy depending on the tumor location in intrahepatic cholangiocarcinoma: focusing on the involvement of below 2nd bile duct confluence
DOI
2022-06
The development and clinical efficacy of simulation training of open duct-to-mucosa pancreaticojejunostomy using pancreas and intestine silicone models
DOI
2022-07
Stool Elastase as an Independent Prognostic Factor in Patients with Pancreatic Head Cancer
DOI
2022-09
Prediction of malignancy in main duct or mixed-type intraductal papillary mucinous neoplasms of the pancreas

Jung, Hye-Sol; Han, Youngmin; Kang, Jae Seung; Sohn, Heeju; Lee, Mirang; Lee, Kyung-Bun; Kim, Hongbeom; Kwon, Wooil; Jang, Jin-Young

Journal of Hepato-Biliary-Pancreatic Sciences, Vol.29 No.9, pp.1014-1024

DOI
2022-09
Impact of surgery on survival outcomes for Bismuth type IV Klatskin tumors
DOI
2022-09
Proper adjuvant therapy in patients with borderline resectable and locally advanced pancreatic cancer who had received neoadjuvant FOLFIRINOX
DOI
2022-09
Oncologic Benefits of Neoadjuvant Treatment versus Upfront Surgery in Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis
DOI
2022-10
Fate of Patients With Intraductal Papillary Mucinous Neoplasms of Pancreas After Resection According to the Pathology and Margin Status Continuously Increasing Risk of Recurrence Even After Curative Resection Suggesting Necessity of Lifetime Surveillance
DOI
1